Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inducible caspase-9 (iCasp9) is a synthetic, engineered form of the human caspase-9 protein designed to function as a "suicide gene" in genetically modified cells. It is activated by small-molecule dimerizers (AP1903/Rimiducid or AP20187), resulting in rapid apoptosis. It is primarily used as a safety switch in adoptive immunotherapies such as CAR-T cell therapy to eliminate transduced cells in case of severe adverse events.
Small-molecule-induced dimerization, leading to caspase-9 activation and apoptosis
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inducible Caspase-9 (iCasp9).